.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Kaizen Medicinals is stocked at 28 licensed dispensaries across California, with the deepest coverage in La Mesa, San Diego, Santa Rosa, Vista, and Capitola. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In July 2026, Kaizen Medicinals concentrated its mix around Concentrates at 78.38% share with 13.02% month-over-month growth and 764.25% year-over-year growth, while Flower held 11.69% share with an 80.60% month-over-month increase and Vapor Pens accounted for 9.93% share with a 4.40% month-over-month decline. The brand’s average price rose 1.67% year over year to $16.80, with Concentrates averaging $15.29 and Flower at $24.77, and the overall brand sales advanced 1002.66% year over year alongside a 588.68% increase over 24 months. The pattern implies that July 2026 momentum is driven primarily by a scaled, price-accessible Concentrates core, with Flower as a fast-accelerating secondary and Vapor Pens acting as a drag on mix stability.
Within California Concentrates, a category rank of 24 alongside 13.02% month-over-month growth and 78.38% share indicates mid-pack penetration where volume expansion outweighs premium positioning, given the $15.29 average price. The 80.60% month-over-month surge in Flower against a 9.93% Vapor Pens share with a 4.40% month-over-month decline suggests the brand is tilting toward inhalables where price elasticity favors conversion in Concentrates while Flower acts as the higher-ticket upsell. The implication is a positioning anchored in value-led Concentrates to gain reach, using Flower’s faster month-over-month trajectory to diversify mix without eroding the core, while de-emphasizing Vapor Pens until margin or velocity improves.
Competitive Landscape
Kaizen Medicinals sits at rank #24 in CA Concentrates in July 2026, improving 80 positions year over year from #104 and rising 10 spots since April 2026 when it was #34; this coincides with reaching a peak rank of #24 in July 2026 and moving into the top 25 while leaders remained stable. In contrast, Raw Garden held at #1 year over year with a 14.2% sales increase, and 710 Labs advanced from #4 to #3 with a 15.9% sales lift, while Punch Extracts / Punch Edibles slipped from #3 to #4 alongside a 21.1% sales decline; the gap between entrenched top-5 brands and Kaizen Medicinals’ move from #104 to #24 implies a late-entrant trajectory driven by velocity gains rather than category-wide tide, suggesting headroom for continued share capture if upward momentum from April 2026 to July 2026 persists.
Notable Products
Forbidden Zkittlez Live Resin Badder (1g) delivered the headline movement in July 2026 with a 426.1% month-over-month surge and a jump into rank 3, outpacing Lemon Reactor Live Resin Badder (1g) at rank 1 with a 55.5% gain. Sugar Melt Live Resin Diamond Sauce (1g) also expanded sharply at 243.5% MoM while moving into rank 4, whereas Golden Tropic Live Resin Badder (1g) slipped 1.3% MoM but held rank 2. With eight of the top ten in Concentrates and two SKUs posting triple-digit MoM increases, the pattern implies Kaizen Medicinals is consolidating share around volatility-friendly, high-velocity concentrates that can be quickly scaled when a strain hits.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
